

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.38399037 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 4.38399037 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.37765571 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.31043450 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.31043450 |
| 6 | cysteine metabolic process (GO:0006534) | 4.15862059 |
| 7 | barbed-end actin filament capping (GO:0051016) | 4.11609632 |
| 8 | serine family amino acid biosynthetic process (GO:0009070) | 3.88141505 |
| 9 | protein localization to endosome (GO:0036010) | 3.75898777 |
| 10 | aldehyde catabolic process (GO:0046185) | 3.74649934 |
| 11 | skin morphogenesis (GO:0043589) | 3.65359457 |
| 12 | viral transcription (GO:0019083) | 3.61192879 |
| 13 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.58312827 |
| 14 | glyoxylate metabolic process (GO:0046487) | 3.57204385 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 3.56861651 |
| 16 | cotranslational protein targeting to membrane (GO:0006613) | 3.55064510 |
| 17 | translational termination (GO:0006415) | 3.54556749 |
| 18 | protein targeting to ER (GO:0045047) | 3.53873353 |
| 19 | L-serine metabolic process (GO:0006563) | 3.53490466 |
| 20 | protein maturation by protein folding (GO:0022417) | 3.45049149 |
| 21 | serine family amino acid metabolic process (GO:0009069) | 3.44431361 |
| 22 | protein localization to endoplasmic reticulum (GO:0070972) | 3.42559895 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 3.39897484 |
| 24 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.35880763 |
| 25 | NADH metabolic process (GO:0006734) | 3.34220046 |
| 26 | glycine metabolic process (GO:0006544) | 3.30147155 |
| 27 | pinocytosis (GO:0006907) | 3.23854167 |
| 28 | response to nitrosative stress (GO:0051409) | 3.21800353 |
| 29 | ribosomal small subunit assembly (GO:0000028) | 3.14486547 |
| 30 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.13523848 |
| 31 | bile acid biosynthetic process (GO:0006699) | 3.11680630 |
| 32 | GDP-mannose metabolic process (GO:0019673) | 3.10978604 |
| 33 | * retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.10796553 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10032931 |
| 35 | lysine catabolic process (GO:0006554) | 3.08084081 |
| 36 | lysine metabolic process (GO:0006553) | 3.08084081 |
| 37 | glycosphingolipid catabolic process (GO:0046479) | 3.07880856 |
| 38 | ethanol oxidation (GO:0006069) | 3.07579846 |
| 39 | valine metabolic process (GO:0006573) | 3.06625285 |
| 40 | translational elongation (GO:0006414) | 3.03969979 |
| 41 | signal peptide processing (GO:0006465) | 3.03789945 |
| 42 | ribosomal small subunit biogenesis (GO:0042274) | 3.03403847 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 3.02610118 |
| 44 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.99071474 |
| 45 | protein carboxylation (GO:0018214) | 2.98190999 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.98190999 |
| 47 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.97850450 |
| 48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.96433787 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 2.93000004 |
| 50 | tryptophan catabolic process (GO:0006569) | 2.93000004 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 2.93000004 |
| 52 | homocysteine metabolic process (GO:0050667) | 2.92194038 |
| 53 | serine family amino acid catabolic process (GO:0009071) | 2.89291424 |
| 54 | glycolipid catabolic process (GO:0019377) | 2.84140257 |
| 55 | L-methionine salvage (GO:0071267) | 2.83709497 |
| 56 | L-methionine biosynthetic process (GO:0071265) | 2.83709497 |
| 57 | amino acid salvage (GO:0043102) | 2.83709497 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.82684634 |
| 59 | basement membrane organization (GO:0071711) | 2.81886738 |
| 60 | negative regulation of fibrinolysis (GO:0051918) | 2.81174181 |
| 61 | kynurenine metabolic process (GO:0070189) | 2.80704718 |
| 62 | viral life cycle (GO:0019058) | 2.80472878 |
| 63 | drug transmembrane transport (GO:0006855) | 2.78584676 |
| 64 | proline biosynthetic process (GO:0006561) | 2.76877362 |
| 65 | aromatic amino acid family metabolic process (GO:0009072) | 2.74836749 |
| 66 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.74122416 |
| 67 | tryptophan metabolic process (GO:0006568) | 2.72000819 |
| 68 | ethanol metabolic process (GO:0006067) | 2.71770208 |
| 69 | NIK/NF-kappaB signaling (GO:0038061) | 2.70268773 |
| 70 | fatty acid elongation (GO:0030497) | 2.69498793 |
| 71 | proteasome assembly (GO:0043248) | 2.68346688 |
| 72 | regulation of protein activation cascade (GO:2000257) | 2.68288985 |
| 73 | fibril organization (GO:0097435) | 2.67343578 |
| 74 | acetyl-CoA metabolic process (GO:0006084) | 2.67066171 |
| 75 | pentose-phosphate shunt (GO:0006098) | 2.66500981 |
| 76 | heme transport (GO:0015886) | 2.66220160 |
| 77 | regulation of early endosome to late endosome transport (GO:2000641) | 2.65158013 |
| 78 | urea cycle (GO:0000050) | 2.64926948 |
| 79 | regulation of necrotic cell death (GO:0010939) | 2.64701077 |
| 80 | urate metabolic process (GO:0046415) | 2.64696596 |
| 81 | NADPH regeneration (GO:0006740) | 2.64213418 |
| 82 | branched-chain amino acid catabolic process (GO:0009083) | 2.63666103 |
| 83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.62830040 |
| 84 | regulation of triglyceride catabolic process (GO:0010896) | 2.62518966 |
| 85 | translational initiation (GO:0006413) | 2.62027766 |
| 86 | stress fiber assembly (GO:0043149) | 2.61855571 |
| 87 | fatty acid beta-oxidation (GO:0006635) | 2.61581649 |
| 88 | regulation of fibrinolysis (GO:0051917) | 2.60707445 |
| 89 | regulation of superoxide anion generation (GO:0032928) | 2.60230178 |
| 90 | branched-chain amino acid metabolic process (GO:0009081) | 2.59874344 |
| 91 | regulation of complement activation (GO:0030449) | 2.59320363 |
| 92 | cellular protein complex disassembly (GO:0043624) | 2.59239557 |
| 93 | cellular aldehyde metabolic process (GO:0006081) | 2.58692826 |
| 94 | xenobiotic catabolic process (GO:0042178) | 2.58329190 |
| 95 | bile acid metabolic process (GO:0008206) | 2.58269035 |
| 96 | cellular copper ion homeostasis (GO:0006878) | 2.58082413 |
| 97 | cofactor catabolic process (GO:0051187) | 2.58005939 |
| 98 | amino-acid betaine metabolic process (GO:0006577) | 2.57985380 |
| 99 | regulation of extracellular matrix disassembly (GO:0010715) | 2.57857243 |
| 100 | hyaluronan catabolic process (GO:0030214) | 2.57630892 |
| 101 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.57400617 |
| 102 | NADP metabolic process (GO:0006739) | 2.57297775 |
| 103 | cellular glucuronidation (GO:0052695) | 2.56604117 |
| 104 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.55503677 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.54775017 |
| 106 | urea metabolic process (GO:0019627) | 2.54517119 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 2.54411282 |
| 108 | plasma lipoprotein particle clearance (GO:0034381) | 2.54239288 |
| 109 | DNA deamination (GO:0045006) | 2.54179993 |
| 110 | glutathione derivative biosynthetic process (GO:1901687) | 2.52851352 |
| 111 | glutathione derivative metabolic process (GO:1901685) | 2.52851352 |
| 112 | alpha-amino acid catabolic process (GO:1901606) | 2.52706632 |
| 113 | cellular ketone body metabolic process (GO:0046950) | 2.51775770 |
| 114 | peptidyl-proline hydroxylation (GO:0019511) | 2.51771031 |
| 115 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51510947 |
| 116 | folic acid metabolic process (GO:0046655) | 2.51088414 |
| 117 | sulfur amino acid biosynthetic process (GO:0000097) | 2.51005992 |
| 118 | complement activation, alternative pathway (GO:0006957) | 2.51004916 |
| 119 | uronic acid metabolic process (GO:0006063) | 2.50960181 |
| 120 | glucuronate metabolic process (GO:0019585) | 2.50960181 |
| 121 | fatty acid catabolic process (GO:0009062) | 2.50148795 |
| 122 | fatty acid oxidation (GO:0019395) | 2.49989024 |
| 123 | protein retention in ER lumen (GO:0006621) | 2.49844316 |
| 124 | fibrinolysis (GO:0042730) | 2.49674977 |
| 125 | regulation of cholesterol metabolic process (GO:0090181) | 2.49208810 |
| 126 | nitrogen cycle metabolic process (GO:0071941) | 2.48900666 |
| 127 | primary alcohol catabolic process (GO:0034310) | 2.48643413 |
| 128 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.48402032 |
| 129 | drug transport (GO:0015893) | 2.48383708 |
| 130 | adhesion of symbiont to host (GO:0044406) | 2.48260673 |
| 131 | Golgi transport vesicle coating (GO:0048200) | 2.48216984 |
| 132 | COPI coating of Golgi vesicle (GO:0048205) | 2.48216984 |
| 133 | translation (GO:0006412) | 2.48115271 |
| 134 | high-density lipoprotein particle remodeling (GO:0034375) | 2.48078565 |
| 135 | hypotonic response (GO:0006971) | 2.47881351 |
| 136 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.47546850 |
| 137 | positive regulation of nuclease activity (GO:0032075) | 2.47279307 |
| 138 | apoptotic cell clearance (GO:0043277) | 2.45980258 |
| 139 | positive regulation of extracellular matrix organization (GO:1903055) | 2.45942512 |
| 140 | adhesion of symbiont to host cell (GO:0044650) | 2.45288003 |
| 141 | virion attachment to host cell (GO:0019062) | 2.45288003 |
| 142 | extracellular fibril organization (GO:0043206) | 2.43827131 |
| 143 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43647102 |
| 144 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.43080627 |
| 145 | regulation of metalloenzyme activity (GO:0048552) | 2.42753424 |
| 146 | protein hydroxylation (GO:0018126) | 2.42435511 |
| 147 | positive regulation of receptor recycling (GO:0001921) | 2.42019953 |
| 148 | membrane raft organization (GO:0031579) | 2.41759081 |
| 149 | glucose catabolic process (GO:0006007) | 2.41364277 |
| 150 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.40495107 |
| 151 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.39857775 |
| 152 | negative regulation of necroptotic process (GO:0060546) | 2.39845509 |
| 153 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.38923519 |
| 154 | cell adhesion mediated by integrin (GO:0033627) | 2.35387784 |
| 155 | response to laminar fluid shear stress (GO:0034616) | 2.34161128 |
| 156 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.33378544 |
| 157 | negative regulation of cell killing (GO:0031342) | 2.33378544 |
| 158 | mannose metabolic process (GO:0006013) | 2.32391619 |
| 159 | regulation of defense response to virus by virus (GO:0050690) | 2.31116738 |
| 160 | vesicle coating (GO:0006901) | 2.30526725 |
| 161 | regulation of necroptotic process (GO:0060544) | 2.27756371 |
| 162 | cell-substrate junction assembly (GO:0007044) | 2.27566156 |
| 163 | regulation of nuclease activity (GO:0032069) | 2.26433185 |
| 164 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.24703513 |
| 165 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.24600836 |
| 166 | response to thyroid hormone (GO:0097066) | 2.23849434 |
| 167 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.23316303 |
| 168 | peptide catabolic process (GO:0043171) | 2.21689899 |
| 169 | ER-nucleus signaling pathway (GO:0006984) | 2.21535029 |
| 170 | hemidesmosome assembly (GO:0031581) | 2.20740855 |
| 171 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.20145874 |
| 172 | angiotensin maturation (GO:0002003) | 2.20096404 |
| 173 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.19623142 |
| 174 | membrane protein ectodomain proteolysis (GO:0006509) | 2.19492816 |
| 175 | cellular response to unfolded protein (GO:0034620) | 2.19337146 |
| 176 | endodermal cell differentiation (GO:0035987) | 2.18546842 |
| 177 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.18095547 |
| 178 | positive regulation of pseudopodium assembly (GO:0031274) | 2.17907350 |
| 179 | tricarboxylic acid metabolic process (GO:0072350) | 2.15983164 |
| 180 | type B pancreatic cell proliferation (GO:0044342) | 2.15542484 |
| 181 | glucose 6-phosphate metabolic process (GO:0051156) | 2.15037409 |
| 182 | ceramide catabolic process (GO:0046514) | 2.14578110 |
| 183 | amyloid precursor protein catabolic process (GO:0042987) | 2.13852129 |
| 184 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.13595320 |
| 185 | UV protection (GO:0009650) | 2.12641977 |
| 186 | adherens junction assembly (GO:0034333) | 2.12302405 |
| 187 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.12063231 |
| 188 | actin filament depolymerization (GO:0030042) | 2.10388187 |
| 189 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.10031806 |
| 190 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.10031806 |
| 191 | cell-substrate adherens junction assembly (GO:0007045) | 2.10029484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.21486975 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.84821712 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.44088329 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.43118153 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25130974 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.19345072 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.99289896 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.85589944 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.84939658 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.71647243 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.63612708 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.47140206 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38943291 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.38886094 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.33443501 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.32027769 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.30517311 |
| 18 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.28486209 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21728788 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.19120300 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14480731 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07379065 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05855589 |
| 24 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.00856512 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00730786 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.00323481 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99664581 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.95644168 |
| 29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.93401919 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.90572622 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86259358 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81755516 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.78774217 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78343219 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.75571105 |
| 36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71783542 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67697603 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65603449 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64083873 |
| 40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.63128322 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.62932328 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61768920 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.61626868 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60559359 |
| 45 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.60087297 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.57219401 |
| 47 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.56707556 |
| 48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.56570548 |
| 49 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55076052 |
| 50 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54886383 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54709960 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53420049 |
| 53 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.52103061 |
| 54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50498986 |
| 55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.49886398 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49135914 |
| 57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.44512679 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44374005 |
| 59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44311189 |
| 60 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.43488950 |
| 61 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42722215 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.41366256 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41271473 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38109766 |
| 65 | * MAF_26560356_Chip-Seq_TH1_Human | 1.37512283 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37472202 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37085649 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35508345 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35079093 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34806650 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34729048 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30887702 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30682581 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30559153 |
| 75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.29744292 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29464818 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28326707 |
| 78 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.27737581 |
| 79 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25906337 |
| 80 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25135054 |
| 81 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25090430 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24044706 |
| 83 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23929800 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23771337 |
| 85 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21864733 |
| 86 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20992661 |
| 87 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20786817 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18817317 |
| 89 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18754744 |
| 90 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17952061 |
| 91 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17916564 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17841114 |
| 93 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16420770 |
| 94 | * MAF_26560356_Chip-Seq_TH2_Human | 1.16190467 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.16172402 |
| 96 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16149219 |
| 97 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.16031417 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15550555 |
| 99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15494064 |
| 100 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.15425262 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13981192 |
| 102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12664464 |
| 103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11873795 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10862487 |
| 105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09842992 |
| 106 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09739479 |
| 107 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08574892 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07690296 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07489966 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04690872 |
| 111 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03584542 |
| 112 | * P68_20966046_ChIP-Seq_HELA_Human | 1.03065450 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02550831 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02322823 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01541426 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01084188 |
| 117 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00894597 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00121771 |
| 119 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99702337 |
| 120 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99468709 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99261613 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98062931 |
| 123 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97781100 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97675536 |
| 125 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97219501 |
| 126 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.97174398 |
| 127 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96884379 |
| 128 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96589784 |
| 129 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.96086592 |
| 130 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95123490 |
| 131 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93014221 |
| 132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92943616 |
| 133 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92665607 |
| 134 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92312661 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91584082 |
| 136 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91326047 |
| 137 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90229921 |
| 138 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90156270 |
| 139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88633638 |
| 140 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87458092 |
| 141 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87414178 |
| 142 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.82912608 |
| 143 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.81774842 |
| 144 | ATF3_27146783_Chip-Seq_COLON_Human | 0.81676055 |
| 145 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81204200 |
| 146 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79421260 |
| 147 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.78565342 |
| 148 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78221730 |
| 149 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.78087338 |
| 150 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.77925174 |
| 151 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77896595 |
| 152 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.77721275 |
| 153 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.77502307 |
| 154 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.77477166 |
| 155 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76856843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.66380309 |
| 2 | MP0005360_urolithiasis | 4.54558381 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.07141203 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.28165133 |
| 5 | MP0005365_abnormal_bile_salt | 3.16381889 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.81625711 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 2.76886080 |
| 8 | MP0009840_abnormal_foam_cell | 2.61805338 |
| 9 | MP0008260_abnormal_autophagy | 2.45223277 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.36668707 |
| 11 | MP0003186_abnormal_redox_activity | 2.34549988 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.34084599 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.23597055 |
| 14 | MP0005332_abnormal_amino_acid | 2.23440077 |
| 15 | MP0003195_calcinosis | 2.14610084 |
| 16 | MP0005083_abnormal_biliary_tract | 2.09436980 |
| 17 | MP0004858_abnormal_nervous_system | 1.94306410 |
| 18 | MP0003252_abnormal_bile_duct | 1.84612471 |
| 19 | MP0010329_abnormal_lipoprotein_level | 1.79693553 |
| 20 | MP0003279_aneurysm | 1.76809760 |
| 21 | MP0003724_increased_susceptibility_to | 1.72926188 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.72023332 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.70785373 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.70602169 |
| 25 | MP0006054_spinal_hemorrhage | 1.68928243 |
| 26 | MP0009379_abnormal_foot_pigmentation | 1.66097219 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.62792189 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.56392846 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.55611211 |
| 30 | MP0003011_delayed_dark_adaptation | 1.54911858 |
| 31 | MP0003303_peritoneal_inflammation | 1.53618604 |
| 32 | MP0003091_abnormal_cell_migration | 1.47502549 |
| 33 | MP0001849_ear_inflammation | 1.47457388 |
| 34 | MP0000609_abnormal_liver_physiology | 1.47375219 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.45982764 |
| 36 | MP0003436_decreased_susceptibility_to | 1.43685225 |
| 37 | MP0001764_abnormal_homeostasis | 1.42636473 |
| 38 | MP0005451_abnormal_body_composition | 1.41777984 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.41342112 |
| 40 | MP0005275_abnormal_skin_tensile | 1.40993708 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.36582521 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.32237672 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.29595027 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.23147740 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.22523204 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.21940522 |
| 47 | MP0003448_altered_tumor_morphology | 1.21193033 |
| 48 | MP0003075_altered_response_to | 1.20674007 |
| 49 | MP0005408_hypopigmentation | 1.20493520 |
| 50 | MP0002796_impaired_skin_barrier | 1.18587782 |
| 51 | MP0008469_abnormal_protein_level | 1.18544777 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.18372385 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.17540332 |
| 54 | MP0003329_amyloid_beta_deposits | 1.17095810 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.16936331 |
| 56 | MP0009785_altered_susceptibility_to | 1.16692525 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.16571497 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.13566970 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.12384380 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 1.11829061 |
| 61 | MP0001756_abnormal_urination | 1.11442410 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.11052088 |
| 63 | MP0003693_abnormal_embryo_hatching | 1.10979984 |
| 64 | MP0001542_abnormal_bone_strength | 1.10233583 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.07758524 |
| 66 | MP0001853_heart_inflammation | 1.07681635 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.05508910 |
| 68 | MP0002132_abnormal_respiratory_system | 1.05308659 |
| 69 | MP0003300_gastrointestinal_ulcer | 1.04740939 |
| 70 | MP0004147_increased_porphyrin_level | 1.04199421 |
| 71 | MP0005387_immune_system_phenotype | 1.03433479 |
| 72 | MP0001790_abnormal_immune_system | 1.03433479 |
| 73 | MP0002060_abnormal_skin_morphology | 1.01800842 |
| 74 | MP0006082_CNS_inflammation | 1.00883659 |
| 75 | MP0003718_maternal_effect | 1.00330106 |
| 76 | MP0005166_decreased_susceptibility_to | 0.98828228 |
| 77 | MP0000678_abnormal_parathyroid_gland | 0.98591964 |
| 78 | MP0005023_abnormal_wound_healing | 0.98105770 |
| 79 | MP0002166_altered_tumor_susceptibility | 0.97464750 |
| 80 | MP0000598_abnormal_liver_morphology | 0.97231438 |
| 81 | MP0000685_abnormal_immune_system | 0.96244168 |
| 82 | MP0000751_myopathy | 0.96232947 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.95697263 |
| 84 | MP0001958_emphysema | 0.95560425 |
| 85 | MP0009763_increased_sensitivity_to | 0.95184086 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.94997581 |
| 87 | MP0001873_stomach_inflammation | 0.94578443 |
| 88 | MP0005025_abnormal_response_to | 0.94252939 |
| 89 | MP0005501_abnormal_skin_physiology | 0.94171902 |
| 90 | MP0001835_abnormal_antigen_presentation | 0.94110748 |
| 91 | MP0001243_abnormal_dermal_layer | 0.93508161 |
| 92 | MP0004233_abnormal_muscle_weight | 0.92161580 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.90483516 |
| 94 | MP0005164_abnormal_response_to | 0.90173668 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.88771839 |
| 96 | MP0010155_abnormal_intestine_physiology | 0.88708657 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 0.88292184 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.87359965 |
| 99 | MP0005390_skeleton_phenotype | 0.87138464 |
| 100 | MP0000747_muscle_weakness | 0.86991307 |
| 101 | MP0001819_abnormal_immune_cell | 0.86701403 |
| 102 | MP0004947_skin_inflammation | 0.86663392 |
| 103 | MP0005503_abnormal_tendon_morphology | 0.86273476 |
| 104 | MP0002420_abnormal_adaptive_immunity | 0.85939100 |
| 105 | MP0009278_abnormal_bone_marrow | 0.85803103 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.85707684 |
| 107 | MP0002723_abnormal_immune_serum | 0.85598468 |
| 108 | MP0009764_decreased_sensitivity_to | 0.85435284 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.85397853 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.84518035 |
| 111 | MP0004510_myositis | 0.84149130 |
| 112 | MP0005621_abnormal_cell_physiology | 0.83218508 |
| 113 | MP0001661_extended_life_span | 0.82971180 |
| 114 | MP0004957_abnormal_blastocyst_morpholog | 0.82905104 |
| 115 | MP0003795_abnormal_bone_structure | 0.82458783 |
| 116 | MP0003868_abnormal_feces_composition | 0.81846579 |
| 117 | MP0003828_pulmonary_edema | 0.80204339 |
| 118 | MP0002419_abnormal_innate_immunity | 0.78128558 |
| 119 | MP0001915_intracranial_hemorrhage | 0.76771057 |
| 120 | MP0009931_abnormal_skin_appearance | 0.75964922 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.75610541 |
| 122 | MP0005330_cardiomyopathy | 0.75386002 |
| 123 | MP0000604_amyloidosis | 0.74818574 |
| 124 | MP0001216_abnormal_epidermal_layer | 0.74756853 |
| 125 | MP0002933_joint_inflammation | 0.74735979 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.74181150 |
| 127 | MP0003950_abnormal_plasma_membrane | 0.74168720 |
| 128 | MP0005000_abnormal_immune_tolerance | 0.73806558 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.73671823 |
| 130 | MP0001800_abnormal_humoral_immune | 0.73618067 |
| 131 | MP0001851_eye_inflammation | 0.73617485 |
| 132 | MP0002148_abnormal_hypersensitivity_rea | 0.73290093 |
| 133 | MP0005409_darkened_coat_color | 0.73161072 |
| 134 | MP0000490_abnormal_crypts_of | 0.72370929 |
| 135 | MP0000343_altered_response_to | 0.71992709 |
| 136 | MP0000858_altered_metastatic_potential | 0.71946734 |
| 137 | MP0004043_abnormal_pH_regulation | 0.71176440 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.71094150 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.69884752 |
| 140 | MP0008004_abnormal_stomach_pH | 0.69553124 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.68428201 |
| 142 | MP0000377_abnormal_hair_follicle | 0.67917083 |
| 143 | MP0001881_abnormal_mammary_gland | 0.67328557 |
| 144 | MP0009642_abnormal_blood_homeostasis | 0.65698305 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.65601985 |
| 146 | MP0004272_abnormal_basement_membrane | 0.65496462 |
| 147 | MP0005376_homeostasis/metabolism_phenot | 0.65401425 |
| 148 | MP0005165_increased_susceptibility_to | 0.64554020 |
| 149 | MP0005395_other_phenotype | 0.63839762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.47887650 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.23708113 |
| 3 | Vertebral compression fractures (HP:0002953) | 4.01869508 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 3.80368734 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.72896061 |
| 6 | Xanthomatosis (HP:0000991) | 3.69644654 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 3.30669064 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.22606743 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.22606743 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.22606743 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.20846464 |
| 12 | Hyperglycinuria (HP:0003108) | 3.18146100 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 3.09863626 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.09863626 |
| 15 | Hyperammonemia (HP:0001987) | 3.06521266 |
| 16 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.94997788 |
| 17 | Hepatic necrosis (HP:0002605) | 2.93335691 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 2.90001859 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 2.89920185 |
| 20 | Hyperglycinemia (HP:0002154) | 2.87773900 |
| 21 | Fat malabsorption (HP:0002630) | 2.85273731 |
| 22 | Hypoglycemic coma (HP:0001325) | 2.84625852 |
| 23 | Atrophic scars (HP:0001075) | 2.80749064 |
| 24 | Generalized aminoaciduria (HP:0002909) | 2.79780366 |
| 25 | Prolonged partial thromboplastin time (HP:0003645) | 2.72309912 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.71295631 |
| 27 | Abnormality of glycolysis (HP:0004366) | 2.69917928 |
| 28 | Increased serum pyruvate (HP:0003542) | 2.69917928 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.68077025 |
| 30 | Increased connective tissue (HP:0009025) | 2.67374829 |
| 31 | Dicarboxylic aciduria (HP:0003215) | 2.66068312 |
| 32 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66068312 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.62853481 |
| 34 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.62347700 |
| 35 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.62347700 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.62104755 |
| 37 | Steatorrhea (HP:0002570) | 2.61278951 |
| 38 | Distal lower limb muscle weakness (HP:0009053) | 2.53787808 |
| 39 | Hepatocellular necrosis (HP:0001404) | 2.53510703 |
| 40 | Achilles tendon contracture (HP:0001771) | 2.53371256 |
| 41 | Fragile skin (HP:0001030) | 2.49129144 |
| 42 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.48334789 |
| 43 | Osteolytic defects of the hand bones (HP:0009699) | 2.48334789 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 2.47233385 |
| 45 | Cerebral edema (HP:0002181) | 2.46788974 |
| 46 | Lethargy (HP:0001254) | 2.46674725 |
| 47 | Acute encephalopathy (HP:0006846) | 2.44653130 |
| 48 | Ketosis (HP:0001946) | 2.44343307 |
| 49 | Glycosuria (HP:0003076) | 2.44244082 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.44244082 |
| 51 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.41585625 |
| 52 | Hypolipoproteinemia (HP:0010981) | 2.40281304 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 2.39696064 |
| 54 | Dilatation of the ascending aorta (HP:0005111) | 2.38800993 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.36759606 |
| 56 | Abnormality of the Achilles tendon (HP:0005109) | 2.36280649 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.34706188 |
| 58 | Complement deficiency (HP:0004431) | 2.33750016 |
| 59 | Cervical subluxation (HP:0003308) | 2.33623179 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33151929 |
| 61 | Increased muscle lipid content (HP:0009058) | 2.32719954 |
| 62 | Abnormal number of erythroid precursors (HP:0012131) | 2.32385261 |
| 63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.31999410 |
| 64 | Gout (HP:0001997) | 2.31999398 |
| 65 | Multiple enchondromatosis (HP:0005701) | 2.31619730 |
| 66 | Distal upper limb amyotrophy (HP:0007149) | 2.31479983 |
| 67 | Upper limb amyotrophy (HP:0009129) | 2.31479983 |
| 68 | Vascular tortuosity (HP:0004948) | 2.31302654 |
| 69 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.30676396 |
| 70 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.30534522 |
| 71 | Abnormality of methionine metabolism (HP:0010901) | 2.28259019 |
| 72 | Wormian bones (HP:0002645) | 2.28218571 |
| 73 | Abnormal cartilage morphology (HP:0002763) | 2.27904572 |
| 74 | Macrocytic anemia (HP:0001972) | 2.27681807 |
| 75 | Cerebral aneurysm (HP:0004944) | 2.27258320 |
| 76 | Abnormality of purine metabolism (HP:0004352) | 2.27071726 |
| 77 | Abnormal hemoglobin (HP:0011902) | 2.26776729 |
| 78 | Proximal tubulopathy (HP:0000114) | 2.26339517 |
| 79 | Aortic dissection (HP:0002647) | 2.26035894 |
| 80 | Hemorrhage of the eye (HP:0011885) | 2.22776832 |
| 81 | Peritonitis (HP:0002586) | 2.22099537 |
| 82 | Blue sclerae (HP:0000592) | 2.21747651 |
| 83 | Abnormality of macrophages (HP:0004311) | 2.20776309 |
| 84 | Premature rupture of membranes (HP:0001788) | 2.20542522 |
| 85 | Amyloidosis (HP:0011034) | 2.19248467 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.18659003 |
| 87 | Ankle contracture (HP:0006466) | 2.17729256 |
| 88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.16001827 |
| 89 | Beaking of vertebral bodies (HP:0004568) | 2.15641381 |
| 90 | Hyperbilirubinemia (HP:0002904) | 2.15420007 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 2.13621912 |
| 92 | Mitochondrial inheritance (HP:0001427) | 2.13371030 |
| 93 | Abnormal gallbladder physiology (HP:0012438) | 2.12592616 |
| 94 | Cholecystitis (HP:0001082) | 2.12592616 |
| 95 | Lipid accumulation in hepatocytes (HP:0006561) | 2.11890847 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11858237 |
| 97 | Arterial tortuosity (HP:0005116) | 2.11317805 |
| 98 | Axonal loss (HP:0003447) | 2.10984111 |
| 99 | Reticulocytopenia (HP:0001896) | 2.10434417 |
| 100 | Purpura (HP:0000979) | 2.10200401 |
| 101 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.10066891 |
| 102 | Vascular calcification (HP:0004934) | 2.10002976 |
| 103 | Bladder diverticulum (HP:0000015) | 2.08954506 |
| 104 | Nonimmune hydrops fetalis (HP:0001790) | 2.07529999 |
| 105 | Ileus (HP:0002595) | 2.07167857 |
| 106 | Elbow flexion contracture (HP:0002987) | 2.05139687 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.04706596 |
| 108 | Delayed CNS myelination (HP:0002188) | 2.04404495 |
| 109 | Conjugated hyperbilirubinemia (HP:0002908) | 2.03214956 |
| 110 | Malnutrition (HP:0004395) | 2.03123444 |
| 111 | Vomiting (HP:0002013) | 2.02963910 |
| 112 | Spinal rigidity (HP:0003306) | 2.02311086 |
| 113 | Short nail (HP:0001799) | 2.01833108 |
| 114 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01403490 |
| 115 | Metabolic acidosis (HP:0001942) | 2.01046793 |
| 116 | Trismus (HP:0000211) | 1.98720295 |
| 117 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.97574073 |
| 118 | Acute necrotizing encephalopathy (HP:0006965) | 1.97439059 |
| 119 | Increased serum ferritin (HP:0003281) | 1.97269534 |
| 120 | Abnormality of complement system (HP:0005339) | 1.96579836 |
| 121 | 3-Methylglutaconic aciduria (HP:0003535) | 1.96006804 |
| 122 | Increased CSF lactate (HP:0002490) | 1.94432558 |
| 123 | Joint hemorrhage (HP:0005261) | 1.94341440 |
| 124 | Pancreatitis (HP:0001733) | 1.94244662 |
| 125 | Nausea (HP:0002018) | 1.94179799 |
| 126 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.93862029 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93065896 |
| 128 | Mucopolysacchariduria (HP:0008155) | 1.93065896 |
| 129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92899472 |
| 130 | Hypertensive crisis (HP:0100735) | 1.92031260 |
| 131 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91763295 |
| 132 | Systemic lupus erythematosus (HP:0002725) | 1.91383905 |
| 133 | Loss of speech (HP:0002371) | 1.91346939 |
| 134 | Ketoacidosis (HP:0001993) | 1.91001156 |
| 135 | Abnormality of iron homeostasis (HP:0011031) | 1.90659830 |
| 136 | Biconcave vertebral bodies (HP:0004586) | 1.90638794 |
| 137 | Lactic acidosis (HP:0003128) | 1.90330919 |
| 138 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90232421 |
| 139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90232421 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90232421 |
| 141 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89986887 |
| 142 | Poor head control (HP:0002421) | 1.89934446 |
| 143 | Hypoalphalipoproteinemia (HP:0003233) | 1.87924567 |
| 144 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87801041 |
| 145 | Aortic aneurysm (HP:0004942) | 1.87699612 |
| 146 | Ragged-red muscle fibers (HP:0003200) | 1.86645690 |
| 147 | CNS demyelination (HP:0007305) | 1.86414919 |
| 148 | Cellulitis (HP:0100658) | 1.86254300 |
| 149 | Polycythemia (HP:0001901) | 1.84953874 |
| 150 | Increased hepatocellular lipid droplets (HP:0006565) | 1.83760506 |
| 151 | Hepatosplenomegaly (HP:0001433) | 1.83360602 |
| 152 | Generalized amyotrophy (HP:0003700) | 1.83243283 |
| 153 | Renal Fanconi syndrome (HP:0001994) | 1.82924894 |
| 154 | Myocardial infarction (HP:0001658) | 1.82658990 |
| 155 | Opisthotonus (HP:0002179) | 1.82343772 |
| 156 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.82211283 |
| 157 | Increased serum lactate (HP:0002151) | 1.82136222 |
| 158 | Aneurysm (HP:0002617) | 1.81945321 |
| 159 | Genu recurvatum (HP:0002816) | 1.81833232 |
| 160 | Recurrent abscess formation (HP:0002722) | 1.81818991 |
| 161 | Bone pain (HP:0002653) | 1.81415064 |
| 162 | Hyperacusis (HP:0010780) | 1.81241585 |
| 163 | Hand muscle atrophy (HP:0009130) | 1.80545369 |
| 164 | Nuclear cataract (HP:0100018) | 1.79373283 |
| 165 | Thin bony cortex (HP:0002753) | 1.78434154 |
| 166 | Reduced antithrombin III activity (HP:0001976) | 1.78319016 |
| 167 | Hyperphosphaturia (HP:0003109) | 1.78261178 |
| 168 | Epidermoid cyst (HP:0200040) | 1.74947823 |
| 169 | Abnormal delivery (HP:0001787) | 1.74250264 |
| 170 | Back pain (HP:0003418) | 1.73657319 |
| 171 | Mitral stenosis (HP:0001718) | 1.73125342 |
| 172 | Disproportionate tall stature (HP:0001519) | 1.72370276 |
| 173 | Mitral regurgitation (HP:0001653) | 1.72250644 |
| 174 | Ulnar bowing (HP:0003031) | 1.70993737 |
| 175 | Abnormality of the nasal mucosa (HP:0000433) | 1.70680759 |
| 176 | Hypertriglyceridemia (HP:0002155) | 1.70404720 |
| 177 | Abnormality of the acetabulum (HP:0003170) | 1.70266029 |
| 178 | Flat acetabular roof (HP:0003180) | 1.70172438 |
| 179 | Petechiae (HP:0000967) | 1.68225828 |
| 180 | Chronic obstructive pulmonary disease (HP:0006510) | 1.67436299 |
| 181 | Obstructive lung disease (HP:0006536) | 1.67436299 |
| 182 | Spondylolisthesis (HP:0003302) | 1.67019292 |
| 183 | Neurofibrillary tangles (HP:0002185) | 1.66270822 |
| 184 | Breech presentation (HP:0001623) | 1.65505788 |
| 185 | Hyperparathyroidism (HP:0000843) | 1.64960927 |
| 186 | Cerebral inclusion bodies (HP:0100314) | 1.64801314 |
| 187 | Type 1 muscle fiber predominance (HP:0003803) | 1.64763885 |
| 188 | Soft skin (HP:0000977) | 1.62030963 |
| 189 | Polygenic inheritance (HP:0010982) | 1.61720104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.17934735 |
| 2 | BCKDK | 3.63281508 |
| 3 | EIF2AK1 | 2.76135643 |
| 4 | PRPF4B | 2.75112660 |
| 5 | BUB1 | 2.51666883 |
| 6 | TESK2 | 2.39795347 |
| 7 | PBK | 2.37759098 |
| 8 | TLK1 | 2.35801536 |
| 9 | SMG1 | 2.29138646 |
| 10 | ERN1 | 2.28842882 |
| 11 | KDR | 2.26755082 |
| 12 | PIM2 | 2.19042704 |
| 13 | STK16 | 2.14262461 |
| 14 | RIPK1 | 2.14198434 |
| 15 | TESK1 | 1.89885335 |
| 16 | LIMK1 | 1.77124548 |
| 17 | RPS6KA4 | 1.75005174 |
| 18 | TAOK2 | 1.70343607 |
| 19 | MST4 | 1.67791844 |
| 20 | LRRK2 | 1.67395778 |
| 21 | MST1R | 1.66133726 |
| 22 | TRIB3 | 1.65413005 |
| 23 | MAP3K11 | 1.63894012 |
| 24 | SCYL2 | 1.63631191 |
| 25 | EPHB1 | 1.59316541 |
| 26 | EIF2AK3 | 1.55105746 |
| 27 | TYK2 | 1.55004339 |
| 28 | FGFR4 | 1.54876470 |
| 29 | PDGFRA | 1.53335159 |
| 30 | IRAK3 | 1.51016089 |
| 31 | STK39 | 1.48790022 |
| 32 | MAP3K3 | 1.46044921 |
| 33 | NTRK1 | 1.45152895 |
| 34 | MAP3K13 | 1.42553238 |
| 35 | WEE1 | 1.39599870 |
| 36 | NEK9 | 1.39453315 |
| 37 | MAP4K1 | 1.39450246 |
| 38 | TBK1 | 1.29369731 |
| 39 | ARAF | 1.17492626 |
| 40 | BLK | 1.16530519 |
| 41 | PTK2 | 1.15988185 |
| 42 | PIK3CG | 1.15549900 |
| 43 | KSR2 | 1.15110402 |
| 44 | ICK | 1.14873702 |
| 45 | MOS | 1.14818554 |
| 46 | ACVR1B | 1.14015659 |
| 47 | STK10 | 1.12320034 |
| 48 | CDK12 | 1.06152649 |
| 49 | ABL2 | 1.05432648 |
| 50 | OXSR1 | 1.05426752 |
| 51 | ILK | 1.01565146 |
| 52 | EPHA2 | 0.97767942 |
| 53 | MAP2K2 | 0.96859312 |
| 54 | ZAP70 | 0.94010751 |
| 55 | MAP3K12 | 0.93869595 |
| 56 | WNK4 | 0.92571509 |
| 57 | MYLK | 0.92165462 |
| 58 | RIPK4 | 0.91185684 |
| 59 | LMTK2 | 0.90892288 |
| 60 | MET | 0.90551815 |
| 61 | MAPKAPK3 | 0.90291752 |
| 62 | DDR2 | 0.89943304 |
| 63 | TEC | 0.87176080 |
| 64 | PRKD2 | 0.86623691 |
| 65 | DYRK3 | 0.86616229 |
| 66 | MAP3K1 | 0.85289479 |
| 67 | EEF2K | 0.83824897 |
| 68 | MAP3K8 | 0.82970905 |
| 69 | PKN2 | 0.79791579 |
| 70 | NME1 | 0.77940177 |
| 71 | PAK4 | 0.77298740 |
| 72 | BRSK2 | 0.77229018 |
| 73 | JAK1 | 0.76960882 |
| 74 | TGFBR2 | 0.76628854 |
| 75 | RPS6KB2 | 0.76289383 |
| 76 | PDPK1 | 0.74942250 |
| 77 | CDC42BPA | 0.74806050 |
| 78 | MAPKAPK5 | 0.74736274 |
| 79 | MAP2K3 | 0.73421397 |
| 80 | LATS2 | 0.71738363 |
| 81 | EPHB2 | 0.70522932 |
| 82 | RPS6KA5 | 0.67422722 |
| 83 | IKBKE | 0.67374321 |
| 84 | TAOK1 | 0.66603690 |
| 85 | MAP3K6 | 0.65763341 |
| 86 | CDK6 | 0.65062338 |
| 87 | BMX | 0.64639873 |
| 88 | MAPK11 | 0.64563361 |
| 89 | PAK2 | 0.63502704 |
| 90 | JAK3 | 0.62961744 |
| 91 | SIK3 | 0.62712762 |
| 92 | PTK6 | 0.62432630 |
| 93 | SIK1 | 0.62311888 |
| 94 | IRAK1 | 0.61831144 |
| 95 | FLT3 | 0.61520223 |
| 96 | NUAK1 | 0.59130636 |
| 97 | BTK | 0.58586639 |
| 98 | MAP3K2 | 0.58369990 |
| 99 | FRK | 0.57850705 |
| 100 | AURKB | 0.57197844 |
| 101 | EPHA3 | 0.57016576 |
| 102 | PRKG2 | 0.55724433 |
| 103 | CSK | 0.54998254 |
| 104 | TTN | 0.54715494 |
| 105 | MAP3K14 | 0.53732462 |
| 106 | ITK | 0.53450467 |
| 107 | CSNK1G3 | 0.52599576 |
| 108 | IRAK4 | 0.52384505 |
| 109 | KIT | 0.52005389 |
| 110 | PIM1 | 0.50037702 |
| 111 | IKBKB | 0.49890357 |
| 112 | CSF1R | 0.49789397 |
| 113 | DYRK1B | 0.49340333 |
| 114 | TXK | 0.49015594 |
| 115 | VRK1 | 0.48931571 |
| 116 | TGFBR1 | 0.48775744 |
| 117 | BCR | 0.48556985 |
| 118 | ROCK2 | 0.48162409 |
| 119 | PAK1 | 0.47811628 |
| 120 | PDK2 | 0.47538616 |
| 121 | AURKA | 0.47124710 |
| 122 | MAP3K10 | 0.47050465 |
| 123 | STK38 | 0.45519232 |
| 124 | MAPKAPK2 | 0.45141109 |
| 125 | CLK1 | 0.45031832 |
| 126 | MTOR | 0.44920536 |
| 127 | BRAF | 0.44173886 |
| 128 | NLK | 0.43445615 |
| 129 | SRPK1 | 0.42451817 |
| 130 | CSNK1G1 | 0.40142904 |
| 131 | JAK2 | 0.39648866 |
| 132 | DAPK1 | 0.38596817 |
| 133 | NEK1 | 0.38197223 |
| 134 | CAMK2G | 0.37745679 |
| 135 | TAOK3 | 0.37530968 |
| 136 | PRKCI | 0.37453826 |
| 137 | TIE1 | 0.36178220 |
| 138 | HCK | 0.35152475 |
| 139 | STK38L | 0.35051875 |
| 140 | RAF1 | 0.35038612 |
| 141 | RET | 0.34838904 |
| 142 | CDK4 | 0.34678997 |
| 143 | DAPK3 | 0.33695037 |
| 144 | MAPK4 | 0.33370036 |
| 145 | GRK6 | 0.33137611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.63214613 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.50549315 |
| 3 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.46957398 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.42151168 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.33675381 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29142197 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.15097931 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15072722 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.15011474 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.08069448 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.06737400 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02316888 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95661344 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.92684305 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.86671682 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.84231536 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80922926 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.80787169 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80359274 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.76215204 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.72009548 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.65849432 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64951435 |
| 24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.64003720 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.61517683 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.60924592 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60694246 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.59392993 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57394334 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56600114 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56541297 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.52684846 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52507323 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49737185 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49041763 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.46484521 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.42899141 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40636805 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.40003818 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38626835 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.36806189 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36360964 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36041769 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.33705089 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32335328 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31042809 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30833954 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30000913 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27831587 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26587580 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26470524 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26258075 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25381340 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24756482 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23132198 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22226779 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22046950 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21993710 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20918930 |
| 60 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20168066 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.19323463 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18399746 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18148539 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14726545 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14662949 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 1.14519450 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13557433 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11237231 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10965045 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 1.08472406 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07642391 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 1.07583612 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 1.06553286 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06545874 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06327956 |
| 76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05674838 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05017249 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 1.04868881 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04513167 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04068851 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.02510040 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 1.01484411 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.99687605 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99486445 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.98666945 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.97147839 |
| 87 | DNA replication_Homo sapiens_hsa03030 | 0.95219150 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.93924854 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93003168 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90165164 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89978170 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88852349 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88818020 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.88234313 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88008520 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.86796117 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.85994055 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85593692 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.84514105 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82108260 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81987026 |
| 102 | RNA polymerase_Homo sapiens_hsa03020 | 0.80806837 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80760628 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.80473471 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79939997 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78338509 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77056986 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.77032733 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75891965 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75792578 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72960815 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70362991 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.68814744 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66856317 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65863898 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64631559 |
| 117 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62584881 |
| 118 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61157354 |
| 119 | Measles_Homo sapiens_hsa05162 | 0.60669956 |
| 120 | Allograft rejection_Homo sapiens_hsa05330 | 0.59000950 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58236180 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57927139 |
| 123 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57660213 |
| 124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57414351 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55477806 |
| 126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54847884 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54790699 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54749000 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54632312 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54374280 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54356400 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54355025 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53823924 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52909244 |
| 135 | Lysosome_Homo sapiens_hsa04142 | 0.52295665 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51671772 |
| 137 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51431785 |
| 138 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51396675 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51291490 |
| 140 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50670084 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50134293 |
| 142 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48400197 |
| 143 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47630489 |
| 144 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47161268 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45693179 |
| 146 | Bile secretion_Homo sapiens_hsa04976 | 0.45411958 |
| 147 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43847270 |
| 148 | Mismatch repair_Homo sapiens_hsa03430 | 0.43746070 |
| 149 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42656083 |
| 150 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.42265408 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42047769 |
| 152 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41559616 |
| 153 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40268683 |
| 154 | Base excision repair_Homo sapiens_hsa03410 | 0.38944421 |
| 155 | Homologous recombination_Homo sapiens_hsa03440 | 0.38561835 |
| 156 | ABC transporters_Homo sapiens_hsa02010 | 0.36604638 |
| 157 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36136607 |
| 158 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36032292 |
| 159 | Legionellosis_Homo sapiens_hsa05134 | 0.35093115 |
| 160 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33440569 |
| 161 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33243491 |
| 162 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31896053 |

